Genomic Vision S.A. buy melinda
Start price
17.03.16
/
50%
€7.46
Target price
23.03.16
€8.50
Performance (%)
14.75%
End price
23.03.16
€8.56
Summary
This prediction ended on 23.03.16 with a price of €8.56. The BUY prediction by melinda finished with a performance of 14.75%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genomic Vision S.A. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to melinda what are the pros and cons of Genomic Vision S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Genomic Vision S.A. diskutieren
technologie
Genomic Vision : obtient la certification qualité NF EN ISO 13485:2012
Stopped prediction by melinda for Genomic Vision S.A.
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.30
12.11.21
12.11.21
€0.50
12.11.22
12.11.22
-78.55%
13.11.22
13.11.22
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.52
29.09.21
29.09.21
€0.75
29.09.22
29.09.22
-20.66%
09.10.21
09.10.21
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.54
13.02.20
13.02.20
-
04.11.21
04.11.21
-2.46%
29.09.21
29.09.21
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€8.60
23.03.16
23.03.16
€20.00
26.09.16
26.09.16
-15.12%
26.09.16
26.09.16
Could be worthwhile Investment >10% per year